Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
04/2010
04/07/2010CN101690776A Chinese medicinal preparation for treating diaphragm muscle spasm
04/07/2010CN101690775A Medicament having qi-supplementing, blood-nourishing, kidney-boosting, yang-reinforcing and anti-cancer effects
04/07/2010CN101690774A Medicine for curing acne
04/07/2010CN101690771A Medicine for curing chronic enteritis
04/07/2010CN101690770A Preparation capable of reducing blood pressure and blood lipid and improving human immunity, and preparation method thereof
04/07/2010CN101690769A External medicament for treating hyperosteogeny and preparation method thereof
04/07/2010CN101690768A Vein and artery relieving pills for impediment of sinew
04/07/2010CN101690766A Gentle bath foam traditional Chinese medicine composite, preparation method thereof and application thereof in preparing drugs and health care products to cure cold-type fatigue syndrome and obesity
04/07/2010CN101690765A Traditional Chinese medicine preparation for treating nervous depression
04/07/2010CN101690764A Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof
04/07/2010CN101690762A Oral preparation for curing nerve ending diseases and Raynaud disease
04/07/2010CN101690759A Health product for improving nutritional anemia and preparation method thereof
04/07/2010CN101690757A Method for preparing bezoar supernatant preparations
04/07/2010CN101690754A Medicine for curing cerebral thrombosis sequela
04/07/2010CN101690750A External medicine for curing hyperosteogeny
04/07/2010CN101690747A Chinese materia medica preparation for treating impotence and preparation method thereof
04/07/2010CN101690736A PRRSV and PCV2 co-infection mouse disease model
04/07/2010CN101690735A Complex microorganism health-protection agent and preparation method thereof
04/07/2010CN101690734A Lactobacillus vaginal capsule and preparation method thereof
04/07/2010CN101690733A Leech enzymatic acetone powder enteric preparation and preparation method and application thereof
04/07/2010CN101690732A Rana chensinensis egg oil health care product and preparation method thereof
04/07/2010CN101690731A Application of umbilical cord Wharton jelly originated mesenchymal stem cells in heart failure cellular transplantation therapy
04/07/2010CN101278865B Partition type tissue engineering spinal cord
04/07/2010CN101199787B Medicament compound for treating skin disease
04/07/2010CN101161265B Medicament taken orally for treating aplastic anemia
04/07/2010CN101130012B Medicine composition for treating toothache and method of preparing the same
04/07/2010CN101088548B Chinese medicine prepn for treating arrhythmia and its prepn process and quality control method
04/07/2010CN101062221B Medicine for treating gastric ulcer and duodenal ulcer
04/07/2010CN101057924B Umbilicus medicine for treating abdominal distension and preparing process thereof
04/06/2010US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
04/06/2010US7691589 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
04/06/2010US7691415 Method for preventing, or reducing the severity of, graft-versus-host disease using pluri-differentiated mesenchymal progenitor cells
04/06/2010US7691391 Monoparamunity inducers based on attenuated rabbit myxomaviruses
04/06/2010US7691388 Compositions comprising Porphyra and methods of making and using thereof
04/06/2010US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody
04/06/2010US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
04/06/2010CA2413456C Stable polymer aqueous/aqueous emulsion system and uses thereof
04/06/2010CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing
04/06/2010CA2339182C Improvement of cardiac function by mesenchymal stem cell transplantation
04/06/2010CA2280930C Protein markers for lung cancer and use thereof
04/06/2010CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
04/06/2010CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells
04/06/2010CA2188919C Monoclonal antibodies which promote central nervous system remyelination
04/01/2010WO2010036961A1 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
04/01/2010WO2010036919A1 Mineral-coated microspheres
04/01/2010WO2010036898A1 Compositions and methods for engineering probiotic yeast
04/01/2010WO2010036876A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
04/01/2010WO2010036357A1 Derivatives of 1-amino-2-cyclobutylethylboronic acid
04/01/2010WO2010036141A1 An implantable neuroendoprosthesis system, a method for preparing same and a procedure for performing of a reconstructive neurosurgical operation
04/01/2010WO2010036132A1 Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus
04/01/2010WO2010036065A2 Pharmaceutical composition for preventing and treating inflammatory diseases, containing an ethyl acetate fraction of dried extract of trachelospermi caulis as an active ingredient, and method for producing the fraction
04/01/2010WO2010035946A1 Composition containing acanthopanax extract as active ingredient for treatment and prevention of gastrointestinal disorders
04/01/2010WO2010035750A1 Method for producing lipid
04/01/2010WO2010035749A1 Method for concentrating lipid
04/01/2010WO2010035013A1 Krill oil powder and krill oil tablets
04/01/2010WO2010034315A1 A deproteinised calf blood preparation for use in prevention or treatment of diabetic peripheral polyneuropathy
04/01/2010WO2010012972A3 Novel bacterial cells and uses thereof
04/01/2010WO2010000127A9 Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale
04/01/2010WO2009154840A3 Compositions and methods using stem cells in cutaneous wound healing
04/01/2010WO2009016451A9 Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound
04/01/2010WO2009010614A8 Use of a new isolate of neospora caninum for the development of diagnostic tests and for preparation of products for treatment and prevention of the infection caused by neospora
04/01/2010US20100081639 Pharmaceutical composition comprising fermented ginseng
04/01/2010US20100080854 Atopic dermatitis inducer
04/01/2010US20100080853 Use of Spongilla Spicules as a Dermabrasion Device or Resurfacing Modality
04/01/2010US20100080840 Hybrid superporous hydrogel scaffold for cornea regeneration
04/01/2010US20100080836 Method and means for culturing osteoblastic cells
04/01/2010US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof
04/01/2010US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
04/01/2010US20100080806 Anti-human trail receptor dr5 monoclonal antibody (ad5-10), method thereof and use of the same
04/01/2010US20100080795 Biodegradable thermogelling polymer
04/01/2010US20100080784 Methods for treating cachexia and lymphopenia
04/01/2010US20100080783 Microbial feed additive
04/01/2010US20100080782 Use of probiotic lactic acid bacteria for balancing the skin's immune system
04/01/2010US20100080781 Preventing Transfusion Related Complications in a Recipient of a Blood Transfusion
04/01/2010US20100080780 Pluripotent autologous stem cells from oral mucosa and methods of use
04/01/2010US20100080779 Methods related to wound healing
04/01/2010US20100080777 Composition containing autologous mononuclear cells and pig collagen scaffold in paste form and its use in the preparation of a medicament for surgical treatment
04/01/2010US20100080776 Method of enhancing an immune response
04/01/2010US20100080775 Recombinant adenoviruses encoding the specific iodine transporter (nis)
04/01/2010US20100080774 Lactococcus promoters and uses thereof
04/01/2010US20100080761 Extracts of Isochrysis sp.
04/01/2010CA2740633A1 Mineral-coated microspheres
04/01/2010CA2739375A1 Derivatives of 1-amino-2-cyclobutylethylboronic acid
04/01/2010CA2738766A1 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
04/01/2010CA2738285A1 Method for producing lipids
04/01/2010CA2738282A1 Method for concentrating lipids
03/2010
03/31/2010EP2169073A1 Vector for the preparation of immunotherapeutical compositions
03/31/2010EP2169057A1 Double-stranded rna originating in lactic acid bacterium
03/31/2010EP2169054A1 Vaccine for swine edema disease
03/31/2010EP2169038A1 A process for decreasing environmental pollutants in an oil or a fat, and a fish feed product
03/31/2010EP2168440A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
03/31/2010EP2167684A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
03/31/2010EP2167649A1 Immunotherapy for hematological malignancies
03/31/2010EP2167648A1 Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
03/31/2010EP2167647A2 Regulatory t cells and methods of making and using same
03/31/2010EP2167109A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
03/31/2010EP2167108A1 Skin-derived precursor cells and uses thereof
03/31/2010EP2167051A1 Microcapsules containing mammals' spermatozoids, insemination dose containing same and method for obtaining same
03/31/2010EP1404808B1 Nucleic acid free ghost preparations
03/31/2010EP1278878B1 Codon optimized eiav vectors
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1259